World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 17 October 2012
Main ID:  NCT01385865
Date of registration: 28/06/2011
Primary sponsor: Ewha Womans University
Public title: Effect of Mulberry Leaf Extract on Blood Glucose
Scientific title: Effect of Mulberry Leaf Extract on Blood Glucose in Subjects With Impaired Fasting Glucose
Date of first enrolment: January 2011
Target sample size: 40
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT01385865
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Basic Science  
Countries of recruitment
Korea, Republic of
Contacts
Name:   Moon Jong Kim, MD
Address: 
Telephone:
Email:
Affiliation:  Bundang CHA Medical Center
Name:   Seok Won Park, MD
Address: 
Telephone:
Email:
Affiliation:  Bundang CHA Medical Center
Name:   Sung Won Kwon, MD
Address: 
Telephone:
Email:
Affiliation:  Bundang CHA Medical Center
Name:   Oran Kwon, Ph.D
Address: 
Telephone:
Email:
Affiliation:  Ewha Womans University
Key inclusion & exclusion criteria

Inclusion Criteria:

- Age: over 20 years

- Fasting glucose: 100mg/dl = ~ = 125mg/dl

- HbA1c: < 6.5%

Exclusion Criteria:

- Subject who has taken medicines, Chinese medicines and Health/Functional Foods which
can affect glucose metabolism in 30 days prior to screening visit

- Subject who has taken part in other clinical trials in 30 days prior to screening
visit

- Subject who is pregnant or breast feeding

- Subject who lost body weight over 4 kg in 30 days prior to screening visit

- Alcoholic

- Heavy smoker (= 20 cigarettes/day)

- Subject who has heart failure, coronary artery disease, uncontrolled hypertension (=
140/90mmHg), diabetes (fasting blood glucose = 126mg/dL), renal dysfunction, liver
failure, hyperthyroidism, hypothyroidism, cancer or mental disease

- Subject who has an allergy to the ingredients of study product



Age minimum: 20 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Prediabetic State
Intervention(s)
Dietary Supplement: Mulberry leaf extract
Dietary Supplement: Placebo
Primary Outcome(s)
Blood glucose change with meal tolerance test [Time Frame: 0wk]
Secondary Outcome(s)
Blood glucose change with meal tolerance test [Time Frame: 4wk]
C-peptide [Time Frame: 0, 4wk]
Fasting blood glucose [Time Frame: 0, 4 wk]
Glycated albumin [Time Frame: 0, 4wk]
High sensitivity C-reactive protein [Time Frame: 0, 4wk]
Insulin [Time Frame: 0, 4wk]
Insulin and C-peptide changes with meal tolerance test [Time Frame: 0, 4 wk]
Lipid profile (triglyceride, total cholesterol, low-density lipoprotein cholesterol, very-low-density lipoprotein cholesterol, high-density lipoprotein cholesterol) [Time Frame: 0, 4wk]
Malondialdehyde [Time Frame: 0, 4wk]
Oxidized low-density lipoprotein [Time Frame: 0, 4wk]
Secondary ID(s)
MLE_Biofood_2
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Bundang CHA Medical Center
Ministry of Knowledge Economy, Korea
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history